Five commonly used traditional Chinese medicine formulas in the treatment of ulcerative colitis: A network meta-analysis

Figure 4 Results of network meta-analysis. Bold font indicates statistical significance (P < 0.05). A: Network meta-analysis (NMA) of the clinical efficacy of traditional Chinese medicine (TCM) adjuvant mesalazine in the treatment of ulcerative colitis [UC; OR (95%CI)]; B: NMA of the tumor necrosis factor of TCM adjuvant mesalazine in the treatment of UC [mean difference (MD; 95%CI)]; C: NMA of the Baron points of TCM adjuvant mesalazine in the treatment of UC [MD (95%CI)]; D: NMA of the recurrence rate of TCM adjuvant mesalazine in the treatment of UC [OR (95%CI)]; E: NMA of the Inflammatory Bowel Disease Questionnaire of TCM adjuvant mesalazine in the treatment of UC [MD (95%CI)]. Chang-yan-ning (CYN), Xi Lei powder (XLS), Baitouweng decoction (BTWT), Shenlingbaizhu powder (SLBZS), Shaoyao decoction (SYT) stand for CYN combined with mesalazine, Xileisan combined with mesalazine, BTWT combined with mesalazine, SLBZS combined with mesalazine, and SYT combined with mesalazine, respectively.